Press Release Telix Announces Positive rPFS Data from ProstACT SELECT Trial of TLX591 rADC Therapy Candidate in Prostate Cancer TLX591 is an investigational anti-PSMA[1] radio-antibody-drug conjugate (rADC) therapy being developed for… CISION PRNewswireMay 31, 2024
Press Release Smartkem Announces Uplisting to Nasdaq MANCHESTER, England, May 31, 2024 /PRNewswire/ — Smartkem, Inc. (OTCQB: SMTK; NASDAQ: SMTK)… CISION PRNewswireMay 31, 2024
Banking Press Release Shepherd Smith Edwards and Kantas: Northstar (Bermuda) and Colorado Bankers Life Insurance Owner Greg Lindberg Found Guilty of Bribery A Second Time Our Seasoned Annuity Fraud Lawyers Are Representing Investors Who Suffered Losses In… CISION PRNewswireMay 31, 2024
Press Release Cat Tuong Group and Wool Producers Australia Sign MOU to Strengthen Bilateral Cooperation SYDNEY, May 31, 2024 /PRNewswire/ — The "NAM DINH – VIETNAM INVESTMENT… CISION PRNewswireMay 31, 2024
Press Release LumaCina announces availability of Oral Morphine pain medication for New Zealanders PERTH, Australia and MIAMI, May 31, 2024 /PRNewswire/ — LumaCina, the pharmaceutical supplier… CISION PRNewswireMay 31, 2024
Press Release X Financial Reports First Quarter 2024 Unaudited Financial Results SHENZHEN, China, May 31, 2024 /PRNewswire/ — X Financial (NYSE: XYF) (the "Company"… CISION PRNewswireMay 31, 2024
Press Release MALAYSIA’S LEADING BUILDING SECURITY SOLUTIONS SPECIALIST, MAG TO BRING MEDIALESS SOLUTION TO PHILIPPINES, VIETNAM, AND INDONESIA MAG has already made significant strides in the regional market with exports… VRITIMESMay 31, 2024
Press Release Ivonescimab Monotherapy Decisively Beats Pembrolizumab Monotherapy Head-to-Head, Achieves Statistically Significant Superiority in PFS in First-Line Treatment of Patients with PD-L1 Positive NSCLC Monotherapy Ivonescimab Achieved Clinically Meaningful PFS Benefit in HARMONi-2 Trial Conducted by… CISION PRNewswireMay 31, 2024
